A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
4/17/2026
BreakingDealsGene TherapyRetina
MeiraGTx Pays J&J $25 Million to Buy Back Gene Therapy Candidate for XLRP
MeiraGTx announced April 16 that it would reacquire all interests in bota-vec, a gene therapy candidate it developed targeting X-linked retinitis pigmentosa (XLRP), from Johnson & Johnson. MeiraGTx...
4/17/2026
BreakingCataractIOLRevenueSurgical
J&J Reports Q1-2026 Surgical Vision Revenue of $396 Million
Johnson & Johnson reported April 14 that its Q1-2026 global surgical vision revenue totaled $396 million, a 9.7 percent increase over $361 million in Q1-2025. Q1-2026 surgical vision revenue in the...
4/17/2026
BreakingDry EyePharmaRegulation
KC Pharmaceuticals Recalls 3.1 Million Eye Drop Bottles over Sterility Concerns
The US FDA reported in March that more than 3.1 million bottles of over-the-counter eye drops sold at major US retailers—including CVS, Walgreens, Kroger, and Rite Aid—had been recalled over steril...
4/17/2026
BreakingCataractSurgical
Pioneering Eye Charities Team Up to Provide Cataract Surgery in Rwanda, Laos
Cure Blindness Project and The Fred Hollows Foundation reported April 2 that they are partnering to end avoidable blindness in Rwanda and Laos by 2035. In addition, they will address the cataract s...
4/17/2026
BreakingCornealDiagnosticOCT
Oculus Launches Pentacam Cornea OCT in US
German company Oculus announced April 8 that it had launched its Pentacam Cornea OCT in the US. The device gained US 510(k) clearance in March 2026. The platform creates Scheimpflug images simultan...
4/17/2026
BreakingDeviceRetinaSurgical
Bausch + Lomb Gains US FDA Clearance for Bi-Blade+ Cutter and Adaptive Fluidics Update
Bausch + Lomb announced April 8 that the US FDA had granted 510(k) clearance for the Bi-Blade+ dual-port cutter and Adaptive Fluidics update for the Stellaris Elite dual-function cataract and vitre...
4/17/2026
BreakingCataractDealsDeviceGlaucomaInstrumentsSurgical
Halma Acquires Surgistar to Augment MST’s Ophthalmic Instrument Portfolio
UK-based Halma, the parent of ophthalmic instrument maker MicroSurgical Technology (MST) announced April 13 that it had acquired Surgistar, of Vista, California, as an add-on to MST. No financial d...
4/17/2026
BreakingDealsDiagnosticDry EyeLaser
Lumibird to Acquire Malaysian Distributor, Establish Southeast Asian Hub
French company Lumibird announced April 8 that it had signed an agreement to acquire its long-term distribution partner Biz Medic, of Kuala Lumpur, Malaysia. The company said, however, that it was ...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.